Abstract
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma and can be separated into two subtypes based upon molecular features with similarities to germinal centre B-cells (GCB-like) or activated B-cells (ABC-like). Here we identify gain of 3q27.2 as being significantly associated with adverse outcome in DLBCL and linked with the ABC-like subtype. This lesion includes the BCL6 oncogene, but does not alter BCL6 transcript levels or target-gene repression. Separately, we identify expression of BCL6 in a subset of human haematopoietic stem/progenitor cells (HSPCs). We therefore hypothesize that BCL6 may act by 'hit-and-run' oncogenesis. We model this hit-and-run mechanism by transiently expressing Bcl6 within murine HSPCs, and find that it causes mature B-cell lymphomas that lack Bcl6 expression and target-gene repression, are transcriptionally similar to post-GCB cells, and show epigenetic changes that are conserved from HSPCs to mature B-cells. Together, these results suggest that BCL6 may function in a 'hit-and-run' role in lymphomagenesis.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Animals
-
Antibodies, Monoclonal, Murine-Derived / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
B-Lymphocytes / metabolism*
-
Cyclophosphamide / therapeutic use
-
DNA Copy Number Variations
-
DNA Methylation
-
DNA-Binding Proteins / genetics*
-
DNA-Binding Proteins / metabolism
-
Doxorubicin / therapeutic use
-
Epigenesis, Genetic
-
Female
-
Gene Expression Regulation, Neoplastic*
-
Hematopoietic Stem Cells / metabolism*
-
Humans
-
Lymphoma, Large B-Cell, Diffuse / drug therapy
-
Lymphoma, Large B-Cell, Diffuse / genetics*
-
Lymphoma, Large B-Cell, Diffuse / metabolism
-
Male
-
Mice
-
Mice, Transgenic
-
Phenotype
-
Prednisone / therapeutic use
-
Prognosis
-
Proto-Oncogene Proteins c-bcl-6
-
Rituximab
-
Vincristine / therapeutic use
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
BCL6 protein, human
-
Bcl6 protein, mouse
-
DNA-Binding Proteins
-
Proto-Oncogene Proteins c-bcl-6
-
R-CHOP protocol
-
Rituximab
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Prednisone
Associated data
-
GEO/GSE36503
-
GEO/GSE56310